Encore to double in size with Empi acquisition
This article was originally published in Clinica
Executive Summary
In a bid to bulk up and put more pressure on the competition, US orthopaedics player Encore Medical has announced its intention to acquire Empi, a privately-held developer of products for pain management, orthopaedic rehabilitation and physical therapy. The transaction is valued at around $360m, of which $325m will be paid in cash and the remainder in 8 million Encore shares.